Concepedia

Author

Baolin Qu

Chinese PLA General HospitalORCID

Also Known As

B L Qu, B Qu, B. L. QU, B. Qu, B.L. Qu, Bao-Lin Qu, Bao-lin QU, Bao-lin Qu, Baodi Qu, Baolin Qu

155

Publications

1.3K

Citations

20

H-Index

27

Concepts

All Affiliations

Chinese PLA General HospitalChinese Academy of Medical Sciences & Peking Union Medical CollegeFujian Provincial Cancer HospitalZhejiang Cancer HospitalChinese People's Liberation Army
BQ

About

Baolin Qu is an author at Chinese PLA General Hospital specializing in radiation oncology, medicine, and radiation therapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

173

2

Health Sciences

3

3

47

3

Cell Biology

1

1

26

4

Immunology

1

1

49

5

Pathology

1

1

51

Baolin Qu

×

37

Publications

1K

Citations

19

H-Index

YearCitations

Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making

Si-Ye Chen, Yong Yang, Shu‐Nan Qi,

Leukemia

2020

125

The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility

Mengyuan Liu, Xinyi Liu, Peisu Suo,

Translational Lung Cancer Research

2020

90

First-line non–anthracycline-based chemotherapy for extranodal nasal-type NK/T-cell lymphoma: a retrospective analysis from the CLCG

Shu‐Nan Qi, Yong Yang, Yu-Qin Song,

Blood Advances

2020

56

Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial

Ligang Xing, Gang Wu, Lühua Wang,

International Journal of Radiation Oncology*Biology*Physics

2020

51

Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG)

Xiu-Wen Deng, Jun-Xin Wu, Tao Wu,

Radiotherapy and Oncology

2018

49

Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma

Xin Liu, Tao Wu, Su-Yu Zhu,

JAMA Network Open

2019

45

Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group

Tao Wu, Yong Yang, Su-Yu Zhu,

Blood Advances

2018

32

Treatment, Survival, and Prognosis of Advanced-Stage Natural Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative Group

Weiping Liu, Yong Yang, Shunan Qi,

Frontiers in Oncology

2021

31

Effect of primary tumor invasion on treatment and survival in extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: a multicenter study from the China Lymphoma Collaborative Group (CLCG)

Shunan Qi, Liming Xu, Zhiyong Yuan,

Leukemia & lymphoma/Leukemia and lymphoma

2019

30

Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study

Yong Yang, Ying Wang, Xin Liu,

Leukemia

2020

30

Page 1